These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9137500)

  • 1. Increased concentration of soluble E-selectin in the sera of breast cancer patients.
    Matsuura N; Narita T; Mitsuoka C; Kimura N; Kannagi R; Imai T; Funahashi H; Takagi H
    Anticancer Res; 1997; 17(2B):1367-72. PubMed ID: 9137500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of soluble E-selectin in women with breast cancer.
    Sheen-Chen SM; Eng HL; Huang CC; Chen WJ
    Br J Surg; 2004 Dec; 91(12):1578-81. PubMed ID: 15386328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between concentrations of circulating soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer.
    Hebbar M; Révillion F; Louchez MM; Vilain MO; Fournier C; Bonneterre J; Peyrat JP
    Clin Cancer Res; 1998 Feb; 4(2):373-80. PubMed ID: 9516925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Soluble adhesion molecules in female patients with breast carcinoma].
    Tesarová P; Kvasnicka J; Umlaufová A; Homolková J; Kalousová M; Tesar V
    Cas Lek Cesk; 2003; 142(5):292-9. PubMed ID: 12920795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble VCAM-1 and E-selectin in breast cancer: relationship with staging and with the detection of circulating cancer cells.
    Silva HC; Garcao F; Coutinho EC; De Oliveira CF; Regateiro FJ
    Neoplasma; 2006; 53(6):538-43. PubMed ID: 17167725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of circulating soluble E-selectin concentrations in node-negative breast cancer patients.
    Hebbar M; Révillion F; Louchez MM; Fournier C; Bonneterre J; Peyrat JP
    Clin Cancer Res; 1999 Jun; 5(6):1427-33. PubMed ID: 10389928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patients.
    Alexiou D; Karayiannakis AJ; Syrigos KN; Zbar A; Sekara E; Michail P; Rosenberg T; Diamantis T
    Am J Gastroenterol; 2003 Feb; 98(2):478-85. PubMed ID: 12591072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin in urological malignancies.
    Perabo F; Sharma S; Gierer R; Wirger A; Fimmers R; Steiner G; Adam M; Schultze-Seemann W
    Indian J Cancer; 2001 Mar; 38(1):1-7. PubMed ID: 14758878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High serum soluble E-selectin levels are associated with postoperative haematogenic recurrence in esophageal squamous cell carcinoma patients.
    Shimada Y; Maeda M; Watanabe G; Imamura M
    Oncol Rep; 2003; 10(4):991-5. PubMed ID: 12792758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of soluble E-selectin in colorectal cancer.
    Uner A; Akcali Z; Unsal D
    Neoplasma; 2004; 51(4):269-74. PubMed ID: 15254658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [E-selectin expression in serum and tissue correlates with distant metastasis of colorectal cancer].
    Kiriyama K; Ye C
    Nihon Rinsho; 1995 Jul; 53(7):1760-4. PubMed ID: 7543166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of soluble intercellular adhesion molecule-1 and E-selectin in metastatic breast carcinoma: correlations with clinicopathological features and prognosis.
    Zhang GJ; Adachi I
    Int J Oncol; 1999 Jan; 14(1):71-7. PubMed ID: 9863011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of hepatocyte growth factor in patients with breast cancer.
    Sheen-Chen SM; Liu YW; Eng HL; Chou FF
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):715-7. PubMed ID: 15767355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotelial activation and flow-mediated vasodilation in young patients with breast cancer.
    Tesarova P; Kalousova M; Zima T; Suchanek M; Malikova I; Kvasnicka J; Duskova D; Tesar V; Vachek J; Krupickova-Kasalova Z; Malik J
    Neoplasma; 2013; 60(6):690-7. PubMed ID: 23906304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased level of circulating adhesion molecules in the sera of breast cancer patients with distant metastases.
    Matsuura N; Narita T; Mitsuoka C; Kimura N; Kannagi R; Imai T; Funahashi H; Takagi H
    Jpn J Clin Oncol; 1997 Jun; 27(3):135-9. PubMed ID: 9255266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
    D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
    Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of serum KL-6, a mucin-like glycoprotein, as a tumor marker for breast cancer.
    Ogawa Y; Ishikawa T; Ikeda K; Nakata B; Sawada T; Ogisawa K; Kato Y; Hirakawa K
    Clin Cancer Res; 2000 Oct; 6(10):4069-72. PubMed ID: 11051258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.